Open AccessP662: PATIENT‐REPORTED OUTCOMES FROM A PHASE 3 RANDOMIZED STUDY OF ZANUBRUTINIB VERSUS BENDAMUSTINE PLUS RITUXIMAB (BR) IN PATIENTS WITH TREATMENT‐NAÏVE (TN) CLL/SLL
Author(s) -
Ghia P.,
Barnes G.,
Yang K.,
Tam C.,
Hillmen P.,
Robak T.,
Brown J.,
Kahl B.,
Tian T.,
Szeto A.,
Paik J.,
Shadman M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845532.14560.fe
Subject(s) - medicine , nausea , quality of life (healthcare) , physical therapy , nursing